$4.2MSeries A, 2 December 2025
Series A to industrialize its processes, scale production, launch ready-to-use kits and grow international sales.
- Amount
- $4.2M
- Stage
- Series A
- Announced
- 2 December 2025
- Lead
- Relyens Innovation Santé (Turenne Santé)
- Other investors
- Octalfa, Evolem, Odiem Capital, BADGE, Angels Santé, business angels
- Use of funds
- Series A to industrialize its processes, scale production, launch ready-to-use kits and grow international sales.
- Checked
- Amount and date checked against the press source
- Source
- Biodetection company Kimialys raises 3.6M euros gazettelabo.fr